Together we will beat cancer

Donate

NICE doesn’t recommend olaparib for patients with certain prostate cancers

NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective

Read More

From smart knives to virtual reality tumours: five innovations in understanding cancer

This entry is part 6 of 6 in the series Cancer Revolutionaries

We dive into five innovations from the world’s greatest minds that could transform the way we deal with cancer

Read More

Help seeking: Why isn’t it as simple as it might sound?

A poll has revealed 50% of UK adults with a possible cancer symptom wait 6 months or more before contacting their GP. Why might people not seek help when they need it?

Read More

Closing the gap: How new screening interventions could reduce inequalities in bowel cancer outcomes

When it comes to diagnosing cancers early, screening is our best available tool. Cancer screening involves testing for early signs…

Read More

‘Normal’ cells and ‘cancer’s surprising circular DNA’: Inside Cancer Grand Challenges Part 2

This entry is part 2 of 2 in the series Inside Cancer Grand Challenges

We’re unpacking two recently funded Cancer Grand Challenges, and introducing the global, multidisciplinary teams taking them on.

Read More

How erectile dysfunction drugs could be the key to overcoming treatment resistance in oesophageal cancer

Researchers have found a drug that targets the tumour microenvironment that could improve treatment for certain cancers. But it might not be the kind of drug you expect. 

Read More

Why haven’t we cured cancer?

This entry is part 4 of 6 in the series Cancer Revolutionaries

Despite big improvements in survival, cancer is still one of the world’s biggest killers. Leading scientists explain why it presents such a challenge – and look at how far we’ve come

Read More

Inside Cancer Grand Challenges Part 1: what makes a grand challenge?

This entry is part 1 of 2 in the series Inside Cancer Grand Challenges

Today, Cancer Grand Challenges announced four new teams that have each received £20 million in funding to take on the biggest challenges in cancer research

Read More

Picking out the patterns: How scientists are finding cancer’s signatures in tumour DNA

An international team of researchers have identified 21 common faults in cancer DNA using an algorithm that works similarly to Netflix

Read More

New study supports extending cervical screening intervals for people who test negative for HPV

A new study confirms that offering cervical screening using HPV testing effectively prevents cervical cancer without the need for as regular screening

Read More